Skip to main content
. 2022 Jul 25;23(15):8177. doi: 10.3390/ijms23158177

Figure 5.

Figure 5

Characterization of SARS-CoV-2 S of the indicated VOCs. (A,B,D,E,G,H,J,K) Percent inhibition of lentiviral vector particles pseudotyped with S of the indicated VOCs. The relevant mutations within the NTD and RBD of the respective mutation are given in brackets. IC50s of the indicated RBD (red) and NTD (blue) cluster antibodies are shown in ng/mL in the brackets. (C,F,I,L) Binding of the RBD (red) and NTD (blue) cluster antibodies and an S2-binding antibody (grey) to S of the VOCs indicated.